![]() |
市场调查报告书
商品编码
1946058
全球动物膳食和治疗营养市场:预测(至2034年)-按产品、动物种类、原料类型、分销管道、应用和地区分類的分析Veterinary Diet & Therapeutic Nutrition Market Forecasts to 2034 - Global Analysis By Product, Animal Type, Ingredient Type, Distribution Channel, Application and By Geography |
||||||
根据 Stratistics MRC 的研究,预计到 2026 年,全球动物饮食和治疗营养市场将达到 51.9 亿美元,在预测期内以 7.6% 的复合年增长率增长,到 2034 年将达到 93.3 亿美元。
动物性饮食和治疗营养是指以科学配方研製的专用动物营养产品,旨在支持伴侣动物和家畜特定健康问题的预防、管理和治疗。这些膳食以兽医学和营养学为基础,针对肥胖、肾臟病、胃肠道疾病、糖尿病、过敏和关节疾病等问题进行研发。治疗营养通常由兽医推荐或处方,透过针对性营养素、控製成分和功能性添加剂,改善健康状况、提高生活品质并支持长期疾病管理,从而辅助临床治疗。
宠物慢性病发生率呈上升趋势
伴侣动物慢性病发生率的不断上升是推动动物饲料和治疗营养市场发展的主要动力。随着宠物老化和久坐生活方式的盛行,肥胖、糖尿病、肾功能障碍、胃肠道过敏、过敏和关节疾病等病症日益普遍。随着兽医学逐渐转向疾病的预防和长期管理,治疗性饮食作为治疗的重要组成部分,其应用也日益广泛。这种对营养干预措施的持续临床依赖,将继续推动全球市场成长。
高纯度标准与基础设施成本
高标准的纯化要求和基础设施需求严重阻碍了市场扩张。兽用治疗性饲料需要严格的品管、专业的加工设施和先进的配方技术,以确保安全性、有效性和符合法规要求。这些因素推高了生产和营运成本,最终导致产品价格上涨。因此,在价格敏感的市场中,产品的可负担性成为一大挑战,限制了市场渗透率。小规模生产商也面临准入壁垒,限制了市场竞争,减缓了创新步伐。
宠物人性化和优质化的趋势
宠物人性化趋势的加速发展为动物饲料和治疗营养市场带来了强劲的成长机会。宠物饲主越来越将宠物视为家庭成员,并将它们的健康和长寿放在首位,从而推动了对高端、针对特定疾病的营养解决方案的需求。这种转变促使人们在实证、兽医推荐的宠物食品上投入更多资金。此外,人们对预防医学和健康餵食方式的日益重视,也促进了专业治疗配方的普及,尤其是在都市区和已开发市场。
严格的监管要求
严格的法规结构对市场成长构成重大威胁。兽用治疗性处方粮必须符合当地监管机构制定的严格的安全性、标籤和功效标准。应对这些复杂的法规会导致研发週期延长、核准成本增加,并加重製造商的合规负担。各国监管要求的差异进一步使全球推广策略变得复杂。未能满足不断变化的标准可能导致产品召回或退出市场,从而造成营运风险并限制创新步伐。
新冠疫情对动物饮食和治疗营养市场产生了复杂的影响。虽然供应链中断和物流挑战暂时影响了生产和分销,但疫情封锁期间宠物饲养量的增加支撑了长期需求成长。人们对宠物健康和预防医学日益增长的关注促使更多人依赖治疗营养。此外,电子商务和远距兽医咨询的普及提高了宠物获取专业营养的途径,在一定程度上抵消了疫情期间面临的短期营运挑战。
在预测期内,小型哺乳动物细分市场预计将占据最大的市场份额。
由于全球范围内饲养的宠物(如犬猫)数量庞大,预计小型哺乳动物市场在预测期内将占据最大的市场份额。这些动物容易罹患慢性病和老龄化疾病,并且需要长期的营养管理。宠物就诊次数的增加、医疗费用支出的增长以及宠物饲主对治疗性营养的日益重视,都进一步巩固了该细分市场的主导地位。针对特定品种和疾病需求的持续产品创新,正在强化该细分市场的市场地位。
预计在预测期内,宠物专卖店细分市场将呈现最高的复合年增长率。
在预测期内,宠物专卖店预计将呈现最高的成长率,这主要得益于其专注于拓展产品系列併提供高端治疗产品。这些商店为寻求兽医推荐营养方案的宠物饲主提供专家建议、精心挑选的产品系列以及更深入的互动体验。都市化加快、可支配收入增加以及消费者对个人化购物体验的日益偏好,都进一步推动了这一成长。此外,与线上平台的整合提升了服务的可近性和便利性,加速了该细分市场在全球范围内的扩张。
在预测期内,北美预计将保持最大的市场份额,这主要得益于其较高的宠物拥有率、先进的兽医基础设施以及对治疗性营养的高度重视。该地区受益于高端宠物食品的早期普及以及透过兽医诊所和专卖店建立的广泛分销网络。优惠的报销政策、成熟的行业巨头以及持续的产品创新进一步巩固了市场渗透率,使北美成为全球收入的主要贡献者。
在预测期内,亚太地区预计将呈现最高的复合年增长率,这主要得益于宠物拥有量的增加、快速的都市化以及可支配收入的成长。人们对宠物健康意识的提高以及兽医服务覆盖范围的扩大,正在推动对治疗性营养食品的需求。此外,西方宠物护理实践的影响以及有组织的零售和电子商务平台的兴起,也促进了市场的加速发展。新兴经济体尚未开发的巨大潜力,也使亚太地区成为一个具有高成长潜力的地区。
According to Stratistics MRC, the Global Veterinary Diet & Therapeutic Nutrition Market is accounted for $5.19 billion in 2026 and is expected to reach $9.33 billion by 2034 growing at a CAGR of 7.6% during the forecast period. Veterinary Diet & Therapeutic Nutrition refers to specialized, scientifically formulated animal nutrition designed to support the prevention, management, and treatment of specific medical conditions in companion and livestock animals. These diets are developed based on veterinary and nutritional science to address disorders such as obesity, renal disease, gastrointestinal issues, diabetes, allergies, and joint conditions. Typically recommended or prescribed by veterinarians, therapeutic nutrition complements clinical treatment by improving health outcomes, enhancing quality of life, and supporting long-term disease management through targeted nutrient composition, controlled ingredients, and functional additives.
Rising Prevalence of Chronic Pet Health Conditions
The increasing incidence of chronic health conditions among companion animals is a major driver of the Veterinary Diet & Therapeutic Nutrition Market. Disorders such as obesity, diabetes, renal dysfunction, gastrointestinal sensitivities, allergies, and joint-related issues are becoming more prevalent due to aging pet populations and sedentary lifestyles. As veterinary care shifts toward preventive and long-term disease management, therapeutic diets are increasingly recommended as an integral component of treatment. This sustained clinical reliance on nutrition-based interventions continues to propel market growth globally.
High purification and infrastructure costs
High purification standards and infrastructure requirements significantly restrain market expansion. Veterinary therapeutic diets demand stringent quality control, specialized processing facilities, and advanced formulation technologies to ensure safety, efficacy, and regulatory compliance. These factors elevate production and operational costs, which are ultimately reflected in higher product prices. As a result, affordability becomes a challenge in price-sensitive markets, limiting widespread adoption. Smaller manufacturers also face barriers to entry, restricting competition and slowing innovation across the market landscape.
Pet Humanization & Premiumization Trend
The accelerating trend of pet humanization presents a strong growth opportunity for the Veterinary Diet & Therapeutic Nutrition Market. Pet owners increasingly regard animals as family members and prioritize their health and longevity, driving demand for premium, condition-specific nutrition solutions. This shift encourages higher spending on veterinarian-recommended diets backed by clinical evidence. Additionally, growing awareness of preventive healthcare and wellness-focused feeding practices supports the adoption of specialized therapeutic formulations, particularly in urban and developed markets.
Stringent Regulatory Requirements
Stringent regulatory frameworks pose a notable threat to market growth. Veterinary therapeutic diets must comply with rigorous safety, labeling, and efficacy standards imposed by regulatory authorities across regions. Navigating these complex regulations increases development timelines, approval costs, and compliance burdens for manufacturers. Variations in regulatory requirements between countries further complicate global expansion strategies. Failure to meet evolving standards can result in product recalls or market withdrawal, creating operational risks and limiting the pace of innovation.
The COVID-19 pandemic had a mixed impact on the Veterinary Diet & Therapeutic Nutrition Market. While supply chain disruptions and logistical challenges temporarily affected production and distribution, increased pet adoption during lockdowns supported long-term demand growth. Heightened focus on pet health and preventive care encouraged greater reliance on therapeutic nutrition. Additionally, the expansion of e-commerce and tele-veterinary consultations improved accessibility to specialized diets, partially offsetting the short-term operational challenges faced during the pandemic period.
The small mammals segment is expected to be the largest during the forecast period
The small mammals segment is expected to account for the largest market share during the forecast period, due to high global population of companion animals such as dogs and cats. These animals are more prone to chronic and age-related conditions that require long-term dietary management. Increased veterinary visits, higher healthcare spending, and greater awareness of therapeutic nutrition among pet owners further support this segment dominance. Continuous product innovation targeting breed- and condition-specific needs strengthens this segment's market position.
The pet specialty stores segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pet specialty stores segment is predicted to witness the highest growth rate, due to their expanding product portfolios and focus on premium and therapeutic offerings. These stores provide specialized guidance, curated selections, and stronger engagement with informed pet owners seeking veterinarian-recommended nutrition. Growing urbanization, rising disposable income and increased preference for personalized purchasing experiences further fuels the growth. Additionally, integration with online platforms enhances accessibility and convenience, accelerating segment expansion globally.
During the forecast period, the North America region is expected to hold the largest market share, due to high pet ownership rates, advanced veterinary healthcare infrastructure, and strong awareness of therapeutic nutrition. The region benefits from early adoption of premium pet food products and widespread availability through veterinary clinics and specialty retailers. Favorable reimbursement structures, established key players, and continuous product innovation further strengthen market penetration, positioning North America as a dominant contributor to global revenue.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to rising pet adoption, rapid urbanization, and increasing disposable income. Growing awareness of pet health and expanding access to veterinary services are driving demand for therapeutic nutrition. Additionally, the influence of Western pet care practices and the emergence of organized retail and e-commerce platforms support market acceleration. Untapped potential in emerging economies further positions Asia Pacific as a high-growth region.
Key players in the market
Some of the key players in Veterinary Diet & Therapeutic Nutrition Market include Purina PetCare (Nestle S.A.), Mars Petcare, Hill's Pet Nutrition (Colgate-Palmolive), Blue Buffalo (General Mills), Royal Canin, Diamond Pet Foods, Veterinary Nutrition Group, Wellness Pet, LLC, NutriSource, Wysong, Natural Balance Pet Foods, Farmina Pet Foods, JustFoodForDogs, EmerAid, LLC, and Virbac.
In October 2025, Mars Petcare and Big Idea Ventures have hand-picked three innovative startups for their 2025 Next Generation Pet Food Program, spotlighting sustainable biotech ingredients and circular feed solutions to transform pet nutrition and reduce environmental impact.
In March 2025, Mars, Incorporated has extended its partnership with the Washington Spirit, becoming the team's Official Petcare Partner, with its logo featured on jerseys and signage, community ticket donations, pet-friendly game nights, and collaborative fan and pet experiences.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.